导出类型

 

Nat Rev Clin Oncol 2017 Apr;14 (4): 201-202. 全文索取
Targeted therapies: Remembrance of things past - discontinuation of second-generation TKI therapy for CML.

PMID: 28169304 [Pubmed - In-Data-Review]

  • Full Text Sources

关联文献

  • 加载中....

检索记录[清空]